Ipsen announced "positive results" in a Phase II trial of <span style="font-size: 13px;">Dysport in patients with urinary incontinence. That could put Ipsen's drug in line for more head-to-head competition with Allergan's Botox, which has successfully expanded into several medical uses.</span>
written on 18.03.2014